Cargando…
Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
Autores principales: | Kevorkian, Jean-Philippe, Riveline, Jean-Pierre, Vandiedonck, Claire, Girard, Diane, Galland, Joris, Féron, Florine, Gautier, Jean-François, Mégarbane, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Infection Association. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462464/ https://www.ncbi.nlm.nih.gov/pubmed/32888976 http://dx.doi.org/10.1016/j.jinf.2020.08.045 |
Ejemplares similares
-
Oral corticoid, aspirin, anticoagulant, colchicine, and furosemide to improve the outcome of hospitalized COVID-19 patients - the COCAA-COLA cohort study
por: Kevorkian, Jean-Philippe, et al.
Publicado: (2021) -
How dysregulation of the immune system promotes diabetes mellitus and cardiovascular risk complications
por: Girard, Diane, et al.
Publicado: (2022) -
Furosemide is associated with acute kidney injury in critically ill patients
por: Levi, T.M., et al.
Publicado: (2012) -
Regulation of inflammation in diabetes: From genetics to epigenomics evidence
por: Diedisheim, Marc, et al.
Publicado: (2020) -
Immediate effects of a bolus of furosemide on hemodynamics in critically ill patients
por: Markou, N, et al.
Publicado: (2003)